$EXPO
EXPONENT INC

2022 Q3 Form 10-Q Financial Statement

#000095017022015145 Filed on August 05, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2021 Q4
Revenue $130.3M $128.5M $116.4M
YoY Change 8.68% 10.3% 17.98%
Cost Of Revenue $12.06M $10.61M $7.938M
YoY Change 62.82% 53.74% 52.65%
Gross Profit $118.2M $117.9M $108.5M
YoY Change 5.11% 7.55% 16.01%
Gross Profit Margin 90.74% 91.74% 93.18%
Selling, General & Admin $65.99M $74.76M $70.28M
YoY Change -14.26% -3.91% 4.27%
% of Gross Profit 55.82% 63.42% 64.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.812M $1.689M $1.645M
YoY Change 13.39% -0.65% -3.24%
% of Gross Profit 1.53% 1.43% 1.52%
Operating Expenses $85.00M $91.76M $76.35M
YoY Change -6.08% -0.72% 4.44%
Operating Profit $45.28M $36.72M $32.12M
YoY Change 54.15% 52.62% 57.39%
Interest Expense $175.0K $21.00K $13.00K
YoY Change 1358.33% -95.67%
% of Operating Profit 0.39% 0.06% 0.04%
Other Income/Expense, Net -$9.845M -$3.910M $257.0K
YoY Change -285.93% -164.44% -93.44%
Pretax Income $35.43M $32.81M $32.39M
YoY Change 2.21% 8.9% 31.46%
Income Tax $9.677M $3.198M $7.815M
% Of Pretax Income 27.31% 9.75% 24.13%
Net Earnings $25.76M $29.61M $24.57M
YoY Change 1.4% -4.02% 35.89%
Net Earnings / Revenue 19.77% 23.05% 21.11%
Basic Earnings Per Share $0.50 $0.56 $0.47
Diluted Earnings Per Share $0.49 $0.56 $460.9K
COMMON SHARES
Basic Shares Outstanding 51.89M 52.42M 52.62M
Diluted Shares Outstanding 52.39M 53.04M 53.31M

Balance Sheet

Concept 2022 Q3 2022 Q2 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $165.6M $215.1M $254.8M
YoY Change -30.98% 0.26% 22.67%
Cash & Equivalents $165.6M $215.1M $297.7M
Short-Term Investments $25.00M
Other Short-Term Assets $15.14M $14.13M $18.74M
YoY Change 0.19% -4.51% 70.35%
Inventory
Prepaid Expenses
Receivables $161.8M $147.5M $139.9M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $342.5M $376.7M $452.8M
YoY Change -13.89% 6.53% 37.79%
LONG-TERM ASSETS
Property, Plant & Equipment $63.92M $61.08M $59.97M
YoY Change 5.95% -22.59% -25.5%
Goodwill $8.607M $8.607M $8.607M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.372M $1.519M $1.521M
YoY Change -98.98% -98.88% -98.7%
Total Long-Term Assets $224.2M $240.9M $231.0M
YoY Change 1.41% 7.81% 12.07%
TOTAL ASSETS
Total Short-Term Assets $342.5M $376.7M $452.8M
Total Long-Term Assets $224.2M $240.9M $231.0M
Total Assets $566.7M $617.5M $683.7M
YoY Change -8.43% 7.03% 27.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.67M $30.84M $21.44M
YoY Change -1.13% 67.61% 15.28%
Accrued Expenses $85.64M $62.60M $92.78M
YoY Change 0.74% 3.3% 35.65%
Deferred Revenue $15.23M $15.67M $19.76M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $127.5M $109.1M $153.0M
YoY Change 3.71% 24.13% 58.7%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.554M $121.9M $2.886M
YoY Change -97.64% 9.3% -96.97%
Total Long-Term Liabilities $2.554M $121.9M $2.886M
YoY Change -97.64% 9.3% -96.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $127.5M $109.1M $153.0M
Total Long-Term Liabilities $2.554M $121.9M $2.886M
Total Liabilities $229.2M $231.0M $266.7M
YoY Change -0.82% 15.84% 39.26%
SHAREHOLDERS EQUITY
Retained Earnings $506.6M $493.4M $478.4M
YoY Change
Common Stock $296.2M $281.5M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $461.6M $398.5M $340.8M
YoY Change
Treasury Stock Shares $14.59M $13.89M $13.59M
Shareholders Equity $337.5M $386.6M $417.1M
YoY Change
Total Liabilities & Shareholders Equity $566.7M $617.5M $683.7M
YoY Change -8.43% 7.03% 27.87%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2021 Q4
OPERATING ACTIVITIES
Net Income $25.76M $29.61M $24.57M
YoY Change 1.4% -4.02% 35.89%
Depreciation, Depletion And Amortization $1.812M $1.689M $1.645M
YoY Change 13.39% -0.65% -3.24%
Cash From Operating Activities $30.17M -$6.352M $24.93M
YoY Change -31.67% -594.32% -11.61%
INVESTING ACTIVITIES
Capital Expenditures -$3.308M $2.606M -$1.191M
YoY Change 89.46% 3.62% -25.56%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$25.00M
YoY Change -100.0% -100.0% -278.55%
Cash From Investing Activities -$3.308M -$2.606M -$26.19M
YoY Change -111.71% -120.87% -311.19%
FINANCING ACTIVITIES
Cash Dividend Paid $12.51M
YoY Change 4.85%
Common Stock Issuance & Retirement, Net $48.55M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -75.13M -73.41M -8.769M
YoY Change 342.01% 171.62% -5.71%
NET CHANGE
Cash From Operating Activities 30.17M -6.352M 24.93M
Cash From Investing Activities -3.308M -2.606M -26.19M
Cash From Financing Activities -75.13M -73.41M -8.769M
Net Change In Cash -48.27M -82.64M -10.03M
YoY Change -187.11% 535.47% -132.05%
FREE CASH FLOW
Cash From Operating Activities $30.17M -$6.352M $24.93M
Capital Expenditures -$3.308M $2.606M -$1.191M
Free Cash Flow $33.48M -$8.958M $26.12M
YoY Change -27.06% 628.29% -12.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Period End Date
DocumentPeriodEndDate
2022-07-01
dei Entity Central Index Key
EntityCentralIndexKey
0000851520
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Trading Symbol
TradingSymbol
EXPO
dei Amendment Flag
AmendmentFlag
false
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-30
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Shell Company
EntityShellCompany
false
dei Entity File Number
EntityFileNumber
0-18655
dei Entity Registrant Name
EntityRegistrantName
EXPONENT, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0218904
dei Entity Address Address Line1
EntityAddressAddressLine1
149 COMMONWEALTH DRIVE
dei Entity Address City Or Town
EntityAddressCityOrTown
MENLO PARK
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94025
dei City Area Code
CityAreaCode
650
dei Local Phone Number
LocalPhoneNumber
326-9400
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
51116758
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
165619000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
297687000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5540000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4423000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
161774000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
139861000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15141000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15214000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
342534000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
452762000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
63921000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
59971000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16139000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14370000
CY2022Q3 us-gaap Goodwill
Goodwill
8607000
CY2021Q4 us-gaap Goodwill
Goodwill
8607000
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
46968000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
46546000
CY2022Q3 expo Deferred Compensation Plan Assets Noncurrent
DeferredCompensationPlanAssetsNoncurrent
87163000
CY2021Q4 expo Deferred Compensation Plan Assets Noncurrent
DeferredCompensationPlanAssetsNoncurrent
99962000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1372000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1521000
CY2022Q3 us-gaap Assets
Assets
566704000
CY2021Q4 us-gaap Assets
Assets
683739000
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
26668000
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
24504000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
80603000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
103552000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
15225000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
19762000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5038000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5164000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
127534000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
152982000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2554000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2886000
CY2022Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
87639000
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
100999000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
11483000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9807000
CY2022Q3 us-gaap Liabilities
Liabilities
229210000
CY2021Q4 us-gaap Liabilities
Liabilities
266674000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65707000
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
66000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
66000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
296098000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
281419000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-3643000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-1983000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3501000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
506605000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
478370000
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
14590000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
13591000
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
461632000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
340807000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
337494000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
417065000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
566704000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
683739000
CY2022Q3 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
118218000
CY2021Q3 expo Revenue Before Reimbursements
RevenueBeforeReimbursements
112468000
expo Revenue Before Reimbursements
RevenueBeforeReimbursements
236088000
expo Revenue Before Reimbursements
RevenueBeforeReimbursements
222047000
CY2022Q3 expo Revenue From Reimbursement
RevenueFromReimbursement
12063000
CY2021Q3 expo Revenue From Reimbursement
RevenueFromReimbursement
7409000
expo Revenue From Reimbursement
RevenueFromReimbursement
22671000
expo Revenue From Reimbursement
RevenueFromReimbursement
14311000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
130281000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
119877000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
258759000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
236358000
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
58446000
CY2021Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
71815000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
127203000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
146353000
CY2022Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
8755000
CY2021Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
8121000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
16920000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
15831000
CY2022Q3 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
12063000
CY2021Q3 expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
7409000
expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
22671000
expo Cost Incurred From Reimbursable Expense
CostIncurredFromReimbursableExpense
14311000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5740000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3160000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9971000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6433000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
85004000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
90505000
us-gaap Operating Expenses
OperatingExpenses
176765000
us-gaap Operating Expenses
OperatingExpenses
182928000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
45277000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
29372000
us-gaap Operating Income Loss
OperatingIncomeLoss
81994000
us-gaap Operating Income Loss
OperatingIncomeLoss
53430000
CY2022Q3 us-gaap Investment Income Net
InvestmentIncomeNet
175000
CY2021Q3 us-gaap Investment Income Net
InvestmentIncomeNet
12000
us-gaap Investment Income Net
InvestmentIncomeNet
196000
us-gaap Investment Income Net
InvestmentIncomeNet
41000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10020000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5283000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13951000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11322000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9845000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5295000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13755000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11363000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
35432000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
34667000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
68239000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
64793000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9677000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9267000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12875000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8545000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
25755000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
25400000
us-gaap Net Income Loss
NetIncomeLoss
55364000
us-gaap Net Income Loss
NetIncomeLoss
56248000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.06
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51890000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52637000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52154000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52587000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52394000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53285000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52725000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53313000
CY2022Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.24
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.20
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.48
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
25755000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
25400000
us-gaap Net Income Loss
NetIncomeLoss
55364000
us-gaap Net Income Loss
NetIncomeLoss
56248000
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1350000
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-32000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1660000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
211000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-61000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-65000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24405000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25307000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
53704000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
56394000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
417065000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
564000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4094000
CY2022Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
48554000
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-310000
CY2022Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
10200000
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-12904000
CY2022Q2 us-gaap Dividends
Dividends
13200000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
29609000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
386564000
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
506000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1845000
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
63289000
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1350000
CY2022Q3 us-gaap Dividends
Dividends
12537000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
25755000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
337494000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
361498000
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
543000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3738000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
243000
CY2021Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
7637000
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-15634000
CY2021Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-4000
CY2021Q2 us-gaap Dividends
Dividends
11261000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
30848000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
377608000
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
480000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1938000
CY2021Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
7000000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-32000
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-32000
CY2021Q3 us-gaap Dividends
Dividends
10595000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
25400000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
387767000
us-gaap Profit Loss
ProfitLoss
55364000
us-gaap Profit Loss
ProfitLoss
56248000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3501000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3298000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
10000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1470000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
932000
us-gaap Share Based Compensation
ShareBasedCompensation
11467000
us-gaap Share Based Compensation
ShareBasedCompensation
10874000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-422000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-549000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23383000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
32110000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3163000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1161000
expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
219000
expo Increase Decrease In Operation Lease Right Of Use Assets
IncreaseDecreaseInOperationLeaseRightOfUseAssets
540000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-582000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11724000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-15680000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2438000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4537000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-816000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23816000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
45452000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5914000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4246000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
9997000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
55000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5914000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
40757000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12904000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15666000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
111843000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7000000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1070000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1023000
us-gaap Payments Of Dividends
PaymentsOfDividends
24859000
us-gaap Payments Of Dividends
PaymentsOfDividends
22354000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-148536000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43997000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1434000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
216000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-132068000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
42428000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
297687000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
197525000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
165619000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
239953000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26007
CY2022Q3 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
97748000
CY2021Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
109342000
CY2022Q3 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
98224000
CY2021Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
110379000
CY2022Q3 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
-11259000
CY2021Q3 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
4676000
expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
-15959000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Items subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts. Actual results could differ from those estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
6701000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
12885000
CY2022Q3 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
4727000
CY2021Q3 expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
5059000
expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
11044000
expo Subcontractor Fees Not Included In Revenues
SubcontractorFeesNotIncludedInRevenues
7394000
CY2022Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
149369000
CY2022Q3 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
98224000
CY2022Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
98224000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
210923000
CY2021Q4 us-gaap Deferred Compensation Liability Current And Noncurrent
DeferredCompensationLiabilityCurrentAndNoncurrent
110379000
CY2021Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
110379000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51890000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52637000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52154000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
52587000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52394000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53285000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52725000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
53313000
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
33333
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
33333
expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
10255000
us-gaap Income Taxes Paid
IncomeTaxesPaid
13763000
us-gaap Income Taxes Paid
IncomeTaxesPaid
5503000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-65000
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
10200000
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
7637000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1950000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
161000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4820000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
573000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5540000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4423000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
161774000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
139861000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4423000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1470000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
353000
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5540000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
130281000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
119877000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
258759000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
236358000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
45277000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
29372000
us-gaap Operating Income Loss
OperatingIncomeLoss
81994000
us-gaap Operating Income Loss
OperatingIncomeLoss
53430000
CY2022Q3 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
4656000
CY2021Q3 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
1499000
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
7451000
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
3805000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1812000
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1642000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3298000
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1364000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
1535000
us-gaap Operating Lease Payments
OperatingLeasePayments
3565000
us-gaap Operating Lease Payments
OperatingLeasePayments
3814000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y2M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.039
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.042
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2753000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5103000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3382000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2551000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2589000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2071000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
18449000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1928000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
16521000

Files In Submission

Name View Source Status
0000950170-22-015145-index-headers.html Edgar Link pending
0000950170-22-015145-index.html Edgar Link pending
0000950170-22-015145.txt Edgar Link pending
0000950170-22-015145-xbrl.zip Edgar Link pending
expo-20220701.htm Edgar Link pending
expo-20220701.xsd Edgar Link pending
expo-20220701_cal.xml Edgar Link unprocessable
expo-20220701_def.xml Edgar Link unprocessable
expo-20220701_htm.xml Edgar Link completed
expo-20220701_lab.xml Edgar Link unprocessable
expo-20220701_pre.xml Edgar Link unprocessable
expo-ex31_1.htm Edgar Link pending
expo-ex31_2.htm Edgar Link pending
expo-ex32_1.htm Edgar Link pending
expo-ex32_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending